Print

MRI Interventions, Inc. (MRIC) Release: Tocagen Inc. to Utilize ClearPoint® Neuro Intervention System for MRI-guided Delivery of Toca 511 in a Study of Patients With Brain Cancer  
6/25/2012 10:32:28 AM

MEMPHIS, Tenn. & MUNICH--(BUSINESS WIRE)--MRI Interventions, Inc. (OTCBB:MRIC) and Brainlab AG today announced an alliance with Tocagen Inc. in the fight against the most aggressive form of brain cancer, recurrent high grade gliomas including glioblastoma multiforme (GBM). Under the arrangement, MRI Interventions’ ClearPoint®Neuro Intervention System will be utilized at selected sites in Tocagen’s ongoing investigational clinical trial for the delivery of Toca 511 into brain tumors under real-time magnetic resonance imaging (MRI) guidance. Patient recruitment is currently underway at one of several potential trial centers for this arm of this multicenter Phase I/II study.
//-->